0001209191-23-010529.txt : 20230217
0001209191-23-010529.hdr.sgml : 20230217
20230217161058
ACCESSION NUMBER: 0001209191-23-010529
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Delaney William E IV
CENTRAL INDEX KEY: 0001812734
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35005
FILM NUMBER: 23642597
MAIL ADDRESS:
STREET 1: C/O ASSEMBLY BIOSCIENCES, INC.
STREET 2: 331 OYSTER POINT BLVD, FOURTH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001426800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 OYSTER POINT BLVD.
STREET 2: FOURTH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (833) 409-4583
MAIL ADDRESS:
STREET 1: 331 OYSTER POINT BLVD.
STREET 2: FOURTH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC
DATE OF NAME CHANGE: 20080211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-16
0
0001426800
ASSEMBLY BIOSCIENCES, INC.
ASMB
0001812734
Delaney William E IV
C/O ASSEMBLY BIOSCIENCES, INC.
331 OYSTER POINT BLVD, FOURTH FLOOR
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
Common Stock
2023-02-16
4
A
0
10000
0.00
A
88919
D
Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On February 16, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024.
Includes 2,500 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on November 14, 2022.
/s/ John O. Gunderson, as Attorney-in-Fact
2023-02-17